🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/03/1989 | 10,26 | 10,32 | 10,12 | 10,26 | -2,46% | 1,94% | 9.920.578 |
| 16/03/1989 | 10,32 | 10,54 | 10,28 | 10,52 | +0,57% | 2,50% | 7.099.781 |
| 15/03/1989 | 10,54 | 10,58 | 10,44 | 10,46 | -0,75% | 1,32% | 4.901.496 |
| 14/03/1989 | 10,54 | 10,54 | 10,44 | 10,54 | +0,95% | 0,94% | 5.048.635 |
| 13/03/1989 | 10,28 | 10,50 | 10,26 | 10,44 | +2,34% | 2,32% | 6.377.290 |
| 10/03/1989 | 10,26 | 10,26 | 10,06 | 10,20 | -0,58% | 1,94% | 5.291.352 |
| 09/03/1989 | 10,34 | 10,38 | 10,24 | 10,26 | -0,19% | 1,35% | 3.596.107 |
| 08/03/1989 | 10,16 | 10,38 | 10,10 | 10,28 | +1,57% | 2,74% | 6.958.930 |
| 07/03/1989 | 10,18 | 10,22 | 10,12 | 10,12 | -0,39% | 0,98% | 3.306.859 |
| 06/03/1989 | 10,24 | 10,24 | 10,16 | 10,16 | +0,20% | 0,78% | 3.259.699 |
| 03/03/1989 | 10,22 | 10,26 | 10,10 | 10,14 | -1,16% | 1,56% | 2.974.853 |
| 02/03/1989 | 10,02 | 10,26 | 10,00 | 10,26 | +1,18% | 2,58% | 5.701.330 |
| 01/03/1989 | 10,18 | 10,24 | 10,04 | 10,14 | -0,19% | 1,95% | 5.850.355 |
| 28/02/1989 | 9,98 | 10,18 | 9,96 | 10,16 | +2,20% | 2,19% | 5.583.115 |
| 27/02/1989 | 9,92 | 10,02 | 9,88 | 9,94 | +0,20% | 1,40% | 3.723.754 |
| 24/02/1989 | 10,10 | 10,10 | 9,88 | 9,92 | -1,77% | 2,17% | 5.602.608 |
| 23/02/1989 | 9,98 | 10,10 | 9,92 | 10,10 | +0,40% | 1,79% | 4.888.291 |
| 22/02/1989 | 10,32 | 10,32 | 10,00 | 10,06 | -2,51% | 3,08% | 4.318.598 |
| 21/02/1989 | 10,38 | 10,38 | 10,24 | 10,32 | -0,19% | 1,34% | 2.807.592 |
| 17/02/1989 | 10,30 | 10,34 | 10,26 | 10,34 | +0,39% | 0,77% | 5.763.581 |
| 16/02/1989 | 10,32 | 10,36 | 10,26 | 10,30 | +1,57% | 0,96% | 6.408.730 |
| 15/02/1989 | 9,96 | 10,14 | 9,94 | 10,14 | +1,80% | 2,00% | 4.294.704 |
| 14/02/1989 | 9,94 | 10,06 | 9,94 | 9,96 | +0,60% | 1,20% | 3.741.989 |
| 13/02/1989 | 9,82 | 9,94 | 9,82 | 9,90 | -0,20% | 1,21% | 5.674.291 |
| 10/02/1989 | 10,08 | 10,08 | 9,74 | 9,92 | -1,58% | 3,35% | 5.882.424 |
| 09/02/1989 | 10,10 | 10,22 | 10,02 | 10,08 | -1,17% | 1,97% | 4.090.344 |
| 08/02/1989 | 10,40 | 10,50 | 10,20 | 10,20 | -1,35% | 2,87% | 4.019.290 |
| 07/02/1989 | 10,24 | 10,56 | 10,24 | 10,34 | +0,19% | 3,11% | 7.250.693 |
| 06/02/1989 | 10,36 | 10,38 | 10,10 | 10,32 | -0,57% | 2,69% | 2.786.842 |
| 03/02/1989 | 10,30 | 10,38 | 10,22 | 10,38 | +0,77% | 1,54% | 3.504.931 |